The neuronal and immune memory systems as supervisors of neural plasticity and aging of the brain: From phenomenology to coding of information

Annals of the New York Academy of Sciences

Volumn 1057, Issue , 2005, Pages 279-295

  Jovanova Nesic, Katica D ^a   Jankovic, Branislav D ^a  

^a Immunology Research Center Belgrade   (Yugoslavia)

Author keywords

Alzheimer's disease; Behavior; Brain lesions; Brain stimulation; Experimental allergic encephalomyelitis; Fetal allotransplantation; Rats

Indexed keywords

6 HYDROXYDOPA; ALCOHOL; ALUMINUM CHLORIDE; ANTIGEN; CHOLINERGIC RECEPTOR BLOCKING AGENT; KAINIC ACID;

AGING; ALLERGIC ENCEPHALOMYELITIS; ALLOTRANSPLANTATION; ALZHEIMER DISEASE; ANTERIOR HYPOTHALAMUS; ANTIGEN RECOGNITION; BEHAVIOR; BRAIN; BRAIN DAMAGE; COGNITIVE DEFECT; CONFERENCE PAPER; ELECTROSTIMULATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; IMMUNOREGULATION; INFORMATION PROCESSING; LEARNING; MAGNETIC STIMULATION; MEMORY; MEMORY T LYMPHOCYTE; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NERVOUS SYSTEM; NERVOUS SYSTEM FUNCTION; NEUROLOGIC DISEASE; NONHUMAN; OLIVARY NUCLEUS; PHENOMENOLOGY; T LYMPHOCYTE SUBPOPULATION; THERMOREGULATION;

EID: 32244434515     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1356.022     Document Type: Conference Paper

References (107)

1. COLEMAN, P., C. FINCH & J. JOSEPH. 1990. The need for multiple time points in aging studies. Neurobiol. Aging 11: 1-2.
2. PIAZZA, P.V. et al. 1991. Dopamine activity is reduced in the prefrontal cortex to develop amphetamine self-administration. Brain Res. 567: 169-174.
3. MEANEY, M.J. et al. 1988. Effects of neonatal handling on age-related impairments associated with the hippocampus. Science 239: 766-768.
4. DELLU, F. et al. 1995. Reactivity to novelty during youth as a predictive factor of cognitive impairment in the elderly: a longitudinal study in rats. Brain Res. 653: 51-56.
5. WEST, R. et al. 2002. Effects of time of day on age differences in working memory. J. Gerontol. B Psychol. Sci. Soc. Sci. 57: 3-10.
6. KORDOWER, J.H. et al. 2001. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann. Neurol. 49: 202-213.
7. CHOE, L.H. et al. 2002. Studies of potential cerehrospinal fluid molecular markers for Alzheimer's disease. Electrophoresis 23: 2247-2251.
8. LOVELL, M.A. & W.R. MARKESBERY. 2001. Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer's disease ventricular cerebrospinal fluid. Arch. Neurol. 58: 392-396.
9. DEMATTOS, R.B. et al. 2002. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in mouse model of Alzheimer's disease. Science 295: 2264-2267.
10. DODART, J.C. et al. 2002. Immunization reverses memory deficits without reducing brain a-beta burden in Alzheimer's disease model. Nature Neurosci. 5: 452-457.
11. PETTIT, D.L., Z. SHAO & J.L. YAKEL. 2001. Beta-Amyloid (1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice. J. Neurosci. 21: 120.
12. SCHMIDT, R. et al. 2002. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia aging study. Ann. Neurol. 52: 168-174.
13. NEWHOUSE, P.A. et al. 2001. Nicotinic treatment of Alzheimer's disease. Biol. Psychiatry 49: 268-278.
14. NEUNDORFER, M.M. et al. 2001. A longitudinal study of the relationship between levels of depression among persons with Alzheimer's disease and level of depression among their family caregivers. J. Gerontol. B Psychol. Sci. Soc. Sci. 55: 301-313.
15. AISEN, P.S. et al. 2003. Effects of rofecoxib or naproxen vs. placebo on Alzheimer's disease progression: a randomized controlled trial. J. Am. Med. Assoc. 289: 2819-2826.
16. POPOVIC, M. et al. 1997. Open field behavior in nucleus basalis magnocellularis-lesioned rats treated with physostigmine and verapamil. Int. J. Neurosci. 91: 181-188.
17. HEPLER, D. et al. 1985. Memory impairments following basal forebrain lesions. Brain Res. 346: 8-14.
18. KESSLER, J., H. MARKOVITSCH & G. SIGG. 1986. Memory related role of the posterior cholinergic system. Int. J. Neurosci. 30: 101-119.
19. LOCoNTE, G. et al. 1982. Lesions of cholinergic forebrain nuclei: changes in avoidance behavior, and scopolamine actions. Pharmacol. Biochem. Behav. 17: 933-937.
20. MIYAMOTO, M. et al. 1985. Lesioning of the rat basal forebrain leads to memory impairments in passive and active avoidance tasks. Brain Res. 328: 97-104.
21. POPOVIC, M. et al. 1997. Effects of physostigmine and verapamile on active avoidance in an experimental model of Alzheimer's disease. Int. J. Neurosci. 90: 87-97.
22. POPOVIC, M. et al. 1996. Behavioral and adaptive status in an experimental model of Alzheimer's disease in rats. Int. J. Neurosci. 86: 281-299.
23. FISHER, A. et al. 1991. Cis-2 methyl-spirol (1,3-oxathiolanee-5-3′) quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease. J. Pharmacol. Exp. Ther. 257: 392-403.
24. OGISHMA, M. et al. 1992. Differential effects of i.c.v. AF64A injection, nucleus basalis of Meynert lesion, and scopolamine on place navigation and open-field behavior of rats. Yakubutsu Seishin Kodo 12: 85-92.
25. WALSH, R.N. & R.A. CUMMINS. 1976. The open-field test: a critical review. Psychol. Bull. 83: 482-504.
26. WENK, H. 1989. The nucleus basalis magnocellularis Meynert (NBmM) complex - a central integrator of coded 'limbic signals' linked to neocortical modular operation? A proposed (heuristic) model of function. J. Hirnforsch. 30: 127-151.
27. POPOVIC, M. et al. 1997. Humoral and cell-mediated immune responses following lesions of the nucleus basalis magnocellularis in the rat. Int. J. Neurosci. 89: 165.
28. MONSONEGO, A. & H.L. WEINER. 2003. Immunotherapeutic approaches to Alzheimer's disease. Science 302: 834-838.
29. SCHORI, H. et al. 2002. Several immunodeficiency has opposite effect on neuronal survival in glutamate-susceptible and resistant mice: adverse effect of B cells. J. Immunol. 169: 2861-2865.
30. COHEN, I.R. & M. SCHWARTZ. 1999. Autoimmune maintenance and neuroprotection of the central nervous system. J. Immunol. 100: 111-114.
31. MILLER, R.A. 1991. Accumulation of hyporesponsive, calcium extruding memory T cells as a key feature of age-dependent immune dysfunction. Clin. Immunol. Immunopathol. 58: 305-317.
32. ARAGA, S., H. KAGIMOTO & K. TAKAHASHI. 1991. Reduced natural killer activity in patients with dementia of the Alzheimer's type. Acta Neurol. Scand. 84: 259-263.
33. + cell-mediated suppressor activity. Neurology 35: 1635-1638.
34. FAUMAN, M.A. 1982. The central nervous system and immune system. Biol. Psychiatry 17: 1459-1482.
35. JANKOVIC, B.D. & N.H. SPECTOR. 1986. Effects on the immune system of lesioning and stimulation of the nervous system: neuroimmunomodulation. In Enkephalins and Endorphins. Stress and the Immune System. N.P. Plotnikoff, R.E. Faith, A.J. Murgo & R.A. Good, Eds.: 189-220. Plenum. New York.
36. JANKOVIC, B.D., K. JOVANOVA-NESIC & B.M. MARKOVIC. 1988. Neuroimmunomodulation: potentiation of delayed hypersensitivity and antibody production by chronic electrical stimulation of rat brain. Int. J. Neurosci. 39: 153-164.
37. JANKOVIC, B.D. 1973. Structural correlates of immune microenvironment, In Microenvironmental Aspects of Immunity, B.D. Jankovic, Ed.: 1-4. Plenum. New York.
38. JOVANOVA-NESIC., V. NIKOUC & B.D. JANKOVIC. 1993. Locus coeruleus and immunity. II. Suppression of experimental allergic encephalomyelitis and hypersensitivity skin reactions in rats with lesioned locus ceruleus. Int. J. Neurosci. 68: 289-294.
39. KORNEVA, E.A. & V.M. KLIMENKO. 1976. Neuronale hypothalamus activitat und homeostatische reactionen. Ergeb. Exp. Med. 23: 373-382.
40. ROSZMAN, T.L. et al. 1982. Hypothalamic-immune interactions. II. The effect of hypothalamic lesions on the ability of adherent spleen cells to limit lymphocyte blastogenesis. Immunology 45: 737-742.
41. ABRAMSKY, O. et al. 1987. Effect of hypothalamic lesions on experimental autoimmune disease in rats. Ann. NY Acad. Sci. 496: 360-365.
42. SPECTOR, N.H. 1980. The "central state" of the hypothalamus in health and disease: old and new concepts. In Physiology of the Hypothalamus. P. Morgane & J. Paksepp, Eds.: 453-517. Dekker. New York.
43. MILLER, R. 1991. Accumulation of hyporesponsive, calcium-extruding memory T cells as a key feature of age-dependent immune dysfunction. Clin. Immunol. Immunopathol. 58: 305-317.
44. HICKEY, W.F., B.L. HSU & H. KIMURA. 1991. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28: 254-260.
45. SLOAN, D.J., M.J. WOOD & H.M. CHARLTON. 1991. The immune response to intracerebral neural graft. Trends Neurosci. 14: 8-14.
46. GAGE, F.H., J. RAY & L.J. FISHER. 1995. Isolation, characterization and use of stem cells from the CNS. Annu. Rev. Neurosci. 18: 159-192.
47. TUSZINSKY, M. & F.H. GAGE. 1995. Maintaining the neural phenotype after injury in the adult CNS. Mol. Neurobiol. 10: 151-166.
48. DUAN, W.M., H. WINDER & P. BRUNDIN. 1995. Temporal pattern of host response against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neural tissue in rats. Exp. Brain Res. 104: 227-242.
49. JOVANOVA-NESIC, K. et al. 1995. Hypothalamic neural graft and immunity in the CNS. The 1995 International Co-Conference on Environmental Pollution an Neuroimmune Interaction an Environmental (ICON): 161.
50. NIETO-SAMPEDRO, M. et al. 1987. Effects of conditioning lesions on transplant survival, connectivity and function. Role of neurotrophic factors. Ann. NY Acad. Sci. 495: 108-119.
51. SOARES, H.D., G.P. SINSON & T.K. MCINTOSH. 1995. Fetal hippocampal transplants attenuate CA3 pyramidal cell death resulting from fluid percussion brain injury in the rat. J. Neurotrauma 12: 1059-1067.
52. STREILAIN, J.W. 1995. Unraveling immune privilege. Science 270: 1158-1159.
53. FADEN, A.I. & S. SALZAM. 1992. Pharmacological strategies in CNS trauma. Trends Pharmacol. Sci. 3: 29-35.
54. SMITH D.H., K. CASEY & T.K. MCINTOSH. 1995. Pharmacological therapy for traumatic brain injury: experimental approach. New Horiz. 3: 562-572.
55. SUN, D., J.N. FHITAKER & B.D. WILSON. 1999. Regulatory T cells in experimental allergic encephalomyelitis. III. Comparison of disease resistance in Lewis and Fisher 344 rats. Eur. J. Immunol. 29: 1101-1106.
56. FRIEDMAN, C. et al. 1999. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurobiology 52: 244-248.
57. MATTSON, M.P. et al. 2000. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis. J. Neurosci. 20: 1358-1364.
58. KIPNIS, J. et al. 2001. Protective autoimmunity in acute and chronic CNS disorders: therapeutic vaccines. J. Neurosci. 21: 4564-4571.
59. SHEVACH, E.M. 2000. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18: 423-449.
60. BELLONE, M. et al. 1999. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors. Eur. J. Immunol. 21: 2303-2310.
61. GOEBELS, N. et al. 2000. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. Brain 123: 508-518.
62. LIWINGSTON, K.D. et al. 1995. Susceptibility to actively-induced murine experimental allergic encephalomyelitis is not linked to genes of T cell receptor or CD3 complexes. Autoimmunity 21: 195-201.
63. KUCHROO, V.K. & H.L. WEINER. 1998. Antigen-driven regulation of experimental autoimmune encephalomyelitis. Res. Immunol. 149: 759-771.
64. JANKOVIC, B.D., L. RAKIC & M. SESTOVIC. 1969. Changes in electrical activity of the cockroach Blatta orientalis L. brain induced by anti-lobster brain antibody. Experientia 25: 1049-1050.
65. JANKOVIC, B.D., J.S. JAKULIC & J. HORVAT. 1982. Delayed skin hypersensitivity reactions to human brain S-100 protein in psychiatric patients. Biol. Psychiatry 17: 687-697.
66. th Int. Congress on Autoimmunity. Budapest. 11: 43.
67. KELLER, R.J., A. GOVINDARAJAN, H-Y. JUNG, et al. 2004. Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell 115: 467-469.
68. SHERRINGTON, C. 1906. The Integrative Action of the Central Nervous System. Yale University Press. New Haven.
69. WESTRICK, R.J. et al. 1988. Alcohol induced blackout. Psychiatry Res. 24: 201-209.
70. PARKS, D.C. et al. 1997. Effects of age on event-based and time-based prospective memory. Psychol. Aging 12: 314-327.
71. CABEZA, R. et al. 1997. Age-related differences in neural activity during memory encoding and retrieval: a positron emission tomography study. Neuroscience 17: 391-400.
72. MESULAM, M.M., C. GEULA & M.A. MORAN. 1987. Anatomy of cholinesterase inhibition in Alzheimer's disease: Effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Ann. Neurol. 45: 345-349.
73. POPOVIC, M. et al. 1995. Effect of verapamil on spontaneous motor activity and two-way avoidance learning in nucleus basalis-lesioned rats. Eur. J. Neurosci. 8: 171.
74. BROWN, F.A. 1969. A hypothesis for extrinsic timing of circadian rhythm. Can. J. Biol. 47: 287-298.
75. SANDYK, R. 1995. Improvement in short-term visual memory by weak electromagnetic fields in Parkinson's disease. Int. J. Neurosci. 81: 67-82.
76. SANDYK, R., P.A. ANNINOS & N. TSAGAS. 1991. Magnetic fields and seasonality of affective illness: implication for therapy. Int. J. Neurosci. 58: 261-267.
77. JOVANOVA-NESIC, K. & D. VUJIC. 1988. Magnetic brain stimulation and humoral immune response in the rat with lesioned anterior hypothalamus. Yugoslav Physiolog. Pharmacol. Acta. Proceedings of the 14th Congress of the Yugoslav Physiological Society, Belgrade, Sept. 20-24: 163-165.
78. JOVANOVA-NESIC, K. & A. SKOKLJEV. 1990. Magnetic brain stimulation and immune response in the rat with lesioned brain structure. Acupuncture Electro-Therapeutic Res. Int. J. 15: 27-35.
79. SANDYK, R. 1994. Alzheimer's disease: improvement of visual memory and visuoconstructive performance by treatment with picotesla range magnetic fields. Int. J. Neurosci. 76: 185-225.
80. STRUYS-PONSAR, C., O. GUILLARD & P. VAN DEN BOSCH DE AGUILAR. 2000. Effects of aluminum exposure on glutamate metabolism is a possible explanation for its toxicity. Exp. Neurol. 163: 157-164.
81. JOVANOVA-NESIC, K. & L. RAKIC. 2004. Ethanol consumption affecting some brain proteins and cortical plasticity might disturb the neural network of long-term memory. The 7th Seminar on Neural Network Applications in Electrical Engineering, NEUREL-2004. IEEE 7: 165-170.
82. CAUHAN, N.B., J.M. LEE & G.J. SIEGEL. 1997. Na,K-ATPase mRNA level and plaque load in Alzheimer's disease. J. Mol. Neurosci. 9: 151-166.
83. SIEGEL, G.J., N.B. CAUHAN & J.M. LEE. 1998. Age-related Na,K,-ATPase mRNA expression and Alzheimer's disease. In Progress in Alzheimer's and Parkinson's Diseases. A. Fisher, I. Hanin & M. Yoshida, Eds.: 113-119. Plenum. New York.
84. HIKMET, K., O. PERNUR & O. BARIA. 2002. Comparison of activities of Na,K-ATPase in brains of rats. Gerontology 48: 279-281.
85. +-ATPase. Biophys. J. 67: 1247-1251.
86. SAVALAINEN, K.M. et al. 1998. Interactions of excitatory neurotransmitters and xenobiotics in excitatory and oxidative stress. Toxicol. Lett. 28: 363-367.
87. HASPEL, P. et al. 1986. Erythrocyte cations and Na,K-ATPase pump activity in athletes and sedentary subjects. Eur. J. Appl. Physiol. Occup. Physiol. 55: 249.
88. KVITNICKAYA-RUZHOVA, T.Y. & A.L. SHAPENKD. 1992. A comparative ultracytochemical and biochemical study of the choroid plexus ATPase in the aging brain. Tsitologya 34: 81-87.
89. 2+-ATPaSe and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer's disease. Neurosci. Lett. 112: 338-342.
90. FLICKER, C. et al. 1983. Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat. Pharmacol. Biochem. Behav. 18: 973-981.
91. BLANK, M. & L. SOO. 2001. Optimal frequencies for magnetic acceleration of cytochrome oxidase and Na,K-ATPase reactions. Bioelectrochemistry 53: 171-174.
92. + transport through human erythrocyte membranes. Stud. Universitatis Babes Boliat, Physica Special issue: 1-12.
93. BLANK, M. & R. GOODMAN. 2003. Initial interactions in electromagnetic fields-induced biosynthesis. J. Cell. Physiol. 199: 359-364.
94. MELENDES, R.I. et al. 2003. Alcohol stimulates the release of dopamine in the ventral pallidum but not in the globus pallidus: a dual probe microdialysis study. Neuropsychopharmacology 28: 939-946.
95. ZERBINATTI, C.V. et al. 2004. Increased soluble amyloid-β peptide and memory deficits in amyloid model mice overexpressing the low density lipoprotein receptor-related protein. Proc. Natl. Acad. Sci. USA 101: 1075.
96. SHALVI, D. & N.A. DECLARIS. 1997. An unsupervised neural networks approach to medical data mining. CIN: Computers, Informatics, Nursing 22: 101-105.
97. LANDAUER, T.K. 1986. How much do people remember? Some estimates of the quantity of learned information in long-term memory. Cogn. Sci. 10: 477-493.
98. th Seminar on Neural Network Applications in Electrical Engineering, NEUREL-2004. IEEE 7: 145-150.
99. CRISTEA, P.D. 2002. Conversation of nitrogenous base sequences into genomic signals. J. Cell. Mol. Med. 6: 279-303.
100. st Int. Symp. on Control, Communication, and Signal Processing in Biological Science, 21-24 March, Tunisia, pp. 743-746.
101. CRISTEA, P.D. 2003. Large scale features in DNA genomic signals. Elsevier Sign. Proc. 83: 871-888.
102. INTERNATIONAL HUMAN GENOME SEQUENCING CONSORTIUM. Initial sequencing and analysis of the human genome. Nature 409: 860-869.
103. VENTER, J.C. 2001. Draft analysis of the human genome by Celera Genomics. Science 291: 1304.
104. th Seminar on Neural Network Applications in Electrical Engineering, NEUREL-2004. IEEE 7: 17-20.
105. BISHOP, C.M. 1995. Network for Pattern Recognition. Oxford University Press. Oxford.
106. VUCETIC, S. 2003. Detection of unusual biological sequences using class-conditional distribution models. Proc. 3rd SIAM Data Mining Conference, pp. 279-283.
107. POKRAJAC, D. et al. 2003. Localized neural network based distributional learning for knowledge discovery in protein databases. Proc. IEEE/INNS Int. Conf. on Neural Networks, Budapest, July, 2004.